120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
膀胱癌血液透析患者降钙素原显著非感染性升高：病例报告
Authors Yan YC , Guo Q, Xu J , Wei Z, Li J
Received 28 September 2025
Accepted for publication 11 January 2026
Published 17 January 2026 Volume 2026:19 569356
DOI https://doi.org/10.2147/IDR.S569356
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Oliver Planz
Yuan Cong Yan,1,2 Qiang Guo,1 Jingjing Xu,1 Zhe Wei,1 Junyun Li1
1Department of Pharmacy, Jincheng People’s Hospital, Jincheng, People’s Republic of China; 2Department of Pharmacy, The Third Hospital of Jincheng, Jincheng, People’s Republic of China
Correspondence: Junyun Li, Department of Pharmacy, Jincheng People’s Hospital, Jincheng, 048000, People’s Republic of China, Email lijunyun888282@sina.com
Background: Here, we present a rare case of a sustained hemodialysis patient with bladder cancer who had the marked elevation of procalcitonin (PCT) in the absence of evidence for infection.
Case Presentation: A patient had significantly elevated PCT but without clinical manifestations of infection. Through evidence-based investigation and collaboration with physicians, clinical pharmacists successfully ruled out infection. Consequently, antibiotics were discontinued, and the patient improved and was discharged from the hospital.
Conclusion: The aim is to remind clinical pharmacists and clinicians to conduct comprehensive examination and judgment when encountering similar cases to reduce the occurrence of misdiagnosis in clinical practice.
Keywords: end-stage renal disease, procalcitonin, sepsis, C-reactive protein, pharmaceutical care
1Department of Pharmacy, Jincheng People’s Hospital, Jincheng, People’s Republic of China; 2Department of Pharmacy, The Third Hospital of Jincheng, Jincheng, People’s Republic of China
Correspondence: Junyun Li, Department of Pharmacy, Jincheng People’s Hospital, Jincheng, 048000, People’s Republic of China, Email lijunyun888282@sina.com
Background: Here, we present a rare case of a sustained hemodialysis patient with bladder cancer who had the marked elevation of procalcitonin (PCT) in the absence of evidence for infection.
Case Presentation: A patient had significantly elevated PCT but without clinical manifestations of infection. Through evidence-based investigation and collaboration with physicians, clinical pharmacists successfully ruled out infection. Consequently, antibiotics were discontinued, and the patient improved and was discharged from the hospital.
Conclusion: The aim is to remind clinical pharmacists and clinicians to conduct comprehensive examination and judgment when encountering similar cases to reduce the occurrence of misdiagnosis in clinical practice.
Keywords: end-stage renal disease, procalcitonin, sepsis, C-reactive protein, pharmaceutical care